Neurometabolic devices developer EnteroMedics has completed the acquisition of BarioSurg.
The acquisition enables EnteroMedics to access the target company’s Gastric Vest System, which is a minimally invasive, laparoscopically implanted medical device being investigated for weight loss in morbidly obese patients.
EnteroMedics has paid $2m in cash, 1.38 million unregistered shares of its common stock, and one million unregistered shares of its conditional convertible preferred stock.
Finesse Medical specialises in developing wound care and skin treatment products using advanced technologies, while Avery, through its business unit Vancive Medical Technologies, provides pressure-sensitive and functional materials for the retail apparel market.
Finesse’s innovative portfolio of silicone gels and polyurethane foam dressings will complement Avery’s existing products in wound care, while it will also provide new global sales and distribution channels for Avery's products.
The acquisition will strengthen Royal Philips’ respiratory care portfolio with the target company’s vest therapy solution and capabilities.
Tissue Regenix plans to purchase CellRight Technologies.
Based in Texas, US, CellRight is a biologics company specialising in the development of human osteoinductive and wound care scaffolds for use in general orthopaedic, dental and sports medicine surgical procedures.